Discovery of Novel FFA4 (GPR120) Receptor Agonists with β-Arrestin2-Biased Characteristics
Future Medicinal Chemistry2015Vol. 7(18), pp. 2429–2437
Citations Over TimeTop 23% of 2015 papers
Abstract
These compounds may serve as the useful toolkits for detecting differential biased mechanism and developing new candidate therapeutic agents of the FFA4 receptor.
Related Papers
- → Novel selective ligands for free fatty acid receptors GPR120 and GPR40(2009)138 cited
- → Characterizing pharmacological ligands to study the long‐chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4(2014)70 cited
- → Recent Advances in Gut Nutrient Chemosensing(2012)55 cited
- → Application of GPCR Structures for Modelling of Free Fatty Acid Receptors(2016)34 cited
- Desensitisation of the human long chain fatty acid receptors FFA1 and FFA4(2017)